{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:56:27Z","timestamp":1781654187743,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong Medical Science and Technology Research Foundation","award":["A2024606"],"award-info":[{"award-number":["A2024606"]}]},{"name":"Guangzhou Science and Technology Plan Project","award":["2024A04J4732"],"award-info":[{"award-number":["2024A04J4732"]}]},{"name":"Guangzhou Zengcheng District Science and Technology Project","award":["2024ZCKJ21"],"award-info":[{"award-number":["2024ZCKJ21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Precancerous gastric lesions (PLGC) represent a critical transitional stage toward gastric cancer, yet effective interventions to halt progression remain limited. Vitexin, a naturally occurring flavonoid, exhibits anti-cancer potential; however, its molecular targets and mechanisms in PLGC have not been fully defined. This study aimed to elucidate the targets and mechanisms of vitexin against PLGC using an integrative strategy combining network pharmacology, molecular docking\/molecular dynamics (MD), and cellular validation. Putative targets of vitexin and PLGC-associated genes were intersected to obtain 33 common targets, followed by protein\u2013protein interaction network construction and pathway enrichment analyses. Molecular docking was performed against core targets, and MD simulations were conducted to assess the stability of the EGFR\u2013vitexin complex. In vitro validation was carried out in MNNG-induced MC cells using cell viability, migration, and invasion assays, phase-contrast imaging, and immunofluorescence staining of EGFR and E-cadherin. Network analysis highlighted CCND1, EGFR, and ABL1 as central nodes and implicated oncogenic programs including cell-cycle regulation and PI3K\u2013Akt signaling pathway. Docking suggested favorable binding of vitexin to the core targets. MD simulations further supported a stable binding mode of vitexin within the EGFR pocket over 100\u00a0ns with preserved global compactness; a late-stage conformational adaptation accompanied by hydrogen-bond network reorganization was observed without signs of global unfolding. Functionally, vitexin reduced MC cell viability in a dose-dependent manner, reaching\u2009~\u200950% inhibition at 20\u00a0\u03bcM, and significantly suppressed cell migration and invasion. Immunofluorescence demonstrated decreased EGFR expression and altered membrane localization, together with restored E-cadherin expression and membrane localization, suggesting a shift toward an epithelial phenotype. Vitexin inhibits PLGC-associated malignant phenotypes through multi-target modulation. Among the identified candidates, EGFR may serve as a putative and functionally relevant target, while modulation of EGFR-associated signaling together with restoration of E-cadherin may contribute to the reversal of EMT-related phenotypes. These findings provide mechanistic and structural support for the further preclinical evaluation of vitexin in preventing gastric cancer progression.<\/jats:p>","DOI":"10.1038\/s41598-026-48952-y","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:46:21Z","timestamp":1776897981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitexin attenuates gastric precancerous lesions with EGFR as a potential target based on network pharmacology and molecular simulations"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiaying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhandong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"48952_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s10120-024-01494-6","volume":"27","author":"YH Li","year":"2024","unstructured":"Li, Y. H. et al. Global burden of young-onset gastric cancer: A systematic trend analysis of the global burden of disease study 2019. Gastric Cancer 27, 684\u2013700. https:\/\/doi.org\/10.1007\/s10120-024-01494-6 (2024).","journal-title":"Gastric Cancer"},{"key":"48952_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5230\/jgc.2024.24.e10","volume":"24","author":"KP Ko","year":"2024","unstructured":"Ko, K. P. Risk factors of gastric cancer and lifestyle modification for prevention. J. Gastric Cancer 24, 99\u2013107. https:\/\/doi.org\/10.5230\/jgc.2024.24.e10 (2024).","journal-title":"J. Gastric Cancer"},{"key":"48952_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"P Pimentel-Nunes","year":"2019","unstructured":"Pimentel-Nunes, P. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of gastrointestinal endoscopy (ESGE), European helicobacter and microbiota study group (EHMSG), European society of pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 51, 365\u2013388. https:\/\/doi.org\/10.1055\/a-0859-1883 (2019).","journal-title":"Endoscopy"},{"key":"48952_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00251-1","author":"J Kim","year":"2022","unstructured":"Kim, J. et al. Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity. npj. Precis. Oncol. https:\/\/doi.org\/10.1038\/s41698-022-00251-1 (2022).","journal-title":"npj. Precis. Oncol."},{"key":"48952_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11051312","author":"VE Reyes","year":"2023","unstructured":"Reyes, V. E. Helicobacter pylori and its role in gastric cancer. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms11051312 (2023).","journal-title":"Microorganisms"},{"key":"48952_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21, 341\u2013352. https:\/\/doi.org\/10.1038\/s41580-020-0237-9 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"48952_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"48952_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110902","author":"D Liang","year":"2023","unstructured":"Liang, D. et al. Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38\/STAT3 pathway. Int. Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2023.110902 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"48952_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5230\/jgc.2020.20.e19","volume":"20","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Advantages of restoring miR-205-3p expression for better prognosis of gastric cancer via prevention of epithelial-mesenchymal transition. J. Gastric Cancer 20, 212\u2013224. https:\/\/doi.org\/10.5230\/jgc.2020.20.e19 (2020).","journal-title":"J. Gastric Cancer"},{"key":"48952_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s43440-024-00664-8","volume":"77","author":"QM Yang","year":"2025","unstructured":"Yang, Q. M., Huan, R., Meng, D. F., Qi, J. W. & Xia, L. Progress in the study of anti-tumor effects and mechanisms of vitexin. Pharmacol. Rep. 77, 124\u2013134. https:\/\/doi.org\/10.1007\/s43440-024-00664-8 (2025).","journal-title":"Pharmacol. Rep."},{"key":"48952_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119272","author":"JY Liu","year":"2025","unstructured":"Liu, J. Y. et al. Vitexin alleviates MNNG-induced chronic atrophic gastritis via inhibiting NLRP3 inflammasome. J. Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2024.119272 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"48952_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1066244","author":"YM Chu","year":"2022","unstructured":"Chu, Y. M. et al. Fuzheng Nizeng Decoction regulated ferroptosis and endoplasmic reticulum stress in the treatment of gastric precancerous lesions: A mechanistic study based on metabolomics coupled with transcriptomics. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1066244 (2022).","journal-title":"Front. Pharmacol."},{"key":"48952_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/toxics12080573","author":"JB Jian","year":"2024","unstructured":"Jian, J. B. et al. METTL3-regulated lncRNA SNHG7 drives MNNG-induced epithelial-mesenchymal transition in gastric precancerous lesions. Toxics https:\/\/doi.org\/10.3390\/toxics12080573 (2024).","journal-title":"Toxics"},{"key":"48952_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118591","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Jianwei Xiaoyan granule ameliorates chronic atrophic gastritis by regulating HIF-1\u03b1-VEGF pathway. J. Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2024.118591 (2024).","journal-title":"J. Ethnopharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48952-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48952-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48952-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:37:58Z","timestamp":1781653078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48952-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48952"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48952-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"18797"}}